Cell-Free DNA BCT is a direct-draw venous whole blood collection device intended for the collection, stabilization and transport of venous whole blood samples for use in conjunction with cell-free DNA next generation sequencing assays that have been cleared or approved for use with samples collected into the Cell-Free DNA BCT device.
Cell-Free DNA BCT stabilizes cell-free DNA for up to 7 days at 6 °C to 37 °C*. It contains a preservative reagent that reduces the release of contaminating cellular genomic DNA that can occur during sample handling, shipping and processing. The cfDNA and CTCs isolated from stored plasma can be used in next generation sequencing assays that have been cleared or approved for use with samples collected into Cell-Free DNA BCT.